Article
TRIB2 supports a high glycolytic phenotype in melanoma cells
2025-11-18
Abstract excerpt
Metabolic adaptation plays a crucial role in driving the progression of human melanoma contributing to therapy resistance and disease relapse. The pseudo serine/threonine kinase Tribbles homolog 2 (TRIB2) is prominently expressed in melanoma tissue, promoting resistance to anti-cancer treatments and correlating with unfavorable clinical outcomes. Despite this understanding, the impact of TRIB2 expression on melano...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 860a14b7-5e60-5f6f-aa1c-50dd30d03162
- DOI
- 10.1101/2025.11.18.689112
